What is Trulieve Cannabis Corp's earnings per share (EPS)?

Trulieve Cannabis Corp (TCNNF) reported diluted earnings per share of -$0.58 for fiscal year 2025. This represents a 26.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Trulieve Cannabis Corp Financials

TCNNF

Trailing 12 months to March 31, 2026

Revenue $1.2B -1.4% YoY

Net Income -$80.3M +51.1% YoY

EPS (Diluted) -$0.58 FY2025 annual

Free Cash Flow $236.6M +297.9% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 7, 2026 Currency USD FYE December

Trulieve Cannabis Corp (TCNNF) reported $1.2B in revenue over the twelve months to Mar 31, 2026, down 1.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TCNNF FY2025 2026-08-29

Operating recovery is being funded by cash generation and debt reduction, while persistent net losses still erode equity.

By FY2025, the company generated $272.8M of operating cash flow despite a -$116.4M net loss, showing that reported earnings and cash economics have materially diverged. That operating cash supported $228.6M of free cash flow and substantial debt reduction, indicating cash is being deployed to deleverage rather than merely offsetting reported losses.

With revenue essentially flat between FY2024 and FY2025, gross margin stayed near 60%, so the recovery was not volume-led. Operating margin rose from 8.2% to 12.2% while SG&A declined, identifying expense reduction as the immediate driver.

Debt-to-equity fell from 0.3x to 0.1x, showing a less debt-dependent balance sheet. Equity nevertheless fell from $1.25B to $1.14B as retained earnings became more negative, so balance-sheet improvement is coming from financing changes rather than accumulated profitability.

Financial Health Signals

Financial health score not available

Trulieve Cannabis Corp does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

1.19

Trulieve Cannabis Corp scores 1.19, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($2.2B) relative to total liabilities ($1.6B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

6/9

Trulieve Cannabis Corp passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

N/A

Trulieve Cannabis Corp reported a net loss of $116.4M while generating $272.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage Adequate

2.26x

Trulieve Cannabis Corp earns $2.26 in operating income for every $1 of interest expense ($143.5M vs $63.5M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.2B

YoY-0.4%

5Y CAGR+17.8%

Trulieve Cannabis Corp generated $1.2B in revenue in fiscal year 2025. This represents a decrease of 0.4% from the prior year.

EBITDA

$261.1M

YoY+24.0%

5Y CAGR+2.5%

Trulieve Cannabis Corp's EBITDA was $261.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 24.0% from the prior year.

Net Income

-$116.4M

YoY+25.0%

Trulieve Cannabis Corp reported -$116.4M in net income in fiscal year 2025. This represents an increase of 25.0% from the prior year.

EPS (Diluted)

-$0.58

YoY+26.6%

Trulieve Cannabis Corp earned -$0.58 per diluted share (EPS) in fiscal year 2025. This represents an increase of 26.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$228.6M

YoY+53.6%

Trulieve Cannabis Corp generated $228.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 53.6% from the prior year.

Cash & Debt

$255.5M

YoY+7.0%

5Y CAGR+11.7%

Trulieve Cannabis Corp held $255.5M in cash against $136.7M in long-term debt as of fiscal year 2025.

Shares Outstanding

192M

YoY+0.7%

Trulieve Cannabis Corp had 192M shares outstanding in fiscal year 2025. This represents an increase of 0.7% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

60.2%

YoY-0.1pp

5Y CAGR-13.9pp

Trulieve Cannabis Corp's gross margin was 60.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.1 percentage points from the prior year.

Operating Margin

12.2%

YoY+3.9pp

5Y CAGR-29.7pp

Trulieve Cannabis Corp's operating margin was 12.2% in fiscal year 2025, reflecting core business profitability. This is up 3.9 percentage points from the prior year.

Net Margin

-9.8%

YoY+3.2pp

5Y CAGR-21.9pp

Trulieve Cannabis Corp's net profit margin was -9.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 3.2 percentage points from the prior year.

Return on Equity

-10.2%

YoY+2.2pp

5Y CAGR-24.3pp

Trulieve Cannabis Corp's ROE was -10.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.2 percentage points from the prior year.

Capital Allocation

Capital Expenditures

$44.2M

YoY-64.0%

5Y CAGR-15.1%

Trulieve Cannabis Corp invested $44.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 64.0% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Share Buybacks

Not reported for fiscal year 2025.

TCNNF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TCNNF quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$1.2B	$1.2B-0.4%	$1.2B+5.1%	$1.1B-7.3%	$1.2B+30.7%	$931.9M+78.7%	$521.5M+106.3%	$252.8M
Cost of Revenue	$472.1M	$470.0M-0.2%	$470.7M-12.9%	$540.6M+2.2%	$529.1M+44.8%	$365.4M+170.4%	$135.1M+121.6%	$61.0M
Gross Profit	$698.0M	$711.2M-0.6%	$715.7M+21.6%	$588.6M-14.6%	$689.1M+21.6%	$566.6M+46.6%	$386.4M+101.4%	$191.8M
SG&A Expenses	$431.3M	$445.2M-12.8%	$510.5M+32.2%	$386.2M+127.9%	$169.5M+70.4%	$99.5M+175.8%	$36.1M+156.2%	$14.1M
Operating Income	$145.9M	$143.5M+46.8%	$97.8M+144.1%	-$221.6M-541.8%	$50.2M-75.4%	$204.1M-6.5%	$218.3M+92.7%	$113.3M
Interest Expense	$60.5M	$63.5M+2.0%	$62.2M-23.8%	$81.6M+11.1%	$73.4M+152.1%	$29.1M+43.9%	$20.2M+123.6%	$9.1M
Income Tax	$177.5M	$208.1M+5.3%	$197.6M+30.5%	$151.4M-7.4%	$163.4M+12.1%	$145.7M+54.3%	$94.5M+86.7%	$50.6M
Net Income	-$80.3M	-$116.4M+25.0%	-$155.1M+70.6%	-$526.8M-114.1%	-$246.1M-1464.6%	$18.0M-71.4%	$63.0M+18.7%	$53.1M
EPS (Diluted)	—	-$0.58+26.6%	-$0.79+65.4%	-$2.28-140.0%	-$0.95	$0.21-60.4%	$0.53+15.2%	$0.46

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$286.8M-2.2%	$293.1M+1.7%	$288.2M-4.6%	$302.1M+1.5%	$297.8M-1.1%	$301.1M+5.9%	$284.3M-6.3%	$303.4M
Cost of Revenue	$116.7M-1.1%	$118.0M-0.3%	$118.3M-0.7%	$119.2M+4.0%	$114.5M+0.4%	$114.1M+2.8%	$111.0M-8.9%	$121.8M
Gross Profit	$170.1M-2.9%	$175.2M+3.1%	$169.9M-7.1%	$182.9M-0.2%	$183.2M-2.0%	$187.0M+7.9%	$173.3M-4.6%	$181.6M
SG&A Expenses	$104.9M-17.0%	$126.3M+27.6%	$99.0M-2.1%	$101.1M-14.9%	$118.8M-24.8%	$157.9M+6.3%	$148.6M+44.9%	$102.6M
Operating Income	$35.7M+133.5%	$15.3M-63.8%	$42.2M-19.8%	$52.6M+57.9%	$33.3M+2447.9%	$1.3M+111.7%	$618K-98.8%	$49.8M
Interest Expense	$13.3M-9.3%	$14.7M-8.7%	$16.1M-1.9%	$16.4M+0.6%	$16.3M+11.5%	$14.6M-16.3%	$17.5M+13.0%	$15.4M
Income Tax	$21.9M-54.4%	$47.9M-9.7%	$53.0M-3.1%	$54.7M+4.3%	$52.5M+10.3%	$47.6M+0.4%	$47.4M+0.4%	$47.2M
Net Income	$2.3M+106.1%	-$37.7M-31.1%	-$28.8M-78.7%	-$16.1M+52.3%	-$33.8M+40.8%	-$57.0M+7.5%	-$61.6M-414.0%	-$12.0M
EPS (Diluted)	$0.02	N/A	-$0.11-57.1%	-$0.07+56.3%	-$0.16	N/A	-$0.32	-$0.04

Not reported in any period shown, so not listed: R&D Expenses.

TCNNF Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TCNNF quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$2.7B-6.1%	$2.9B+5.2%	$2.7B-19.7%	$3.4B-0.3%	$3.4B+321.2%	$809.8M	N/A
Current Assets	$562.7M-6.9%	$604.6M+26.6%	$477.3M-19.6%	$593.5M+13.2%	$524.4M+100.6%	$261.5M	N/A
Cash & Equivalents	$255.5M+7.0%	$238.8M+18.6%	$201.4M-2.8%	$207.2M-8.6%	$226.6M+54.5%	$146.7M+59.8%	$91.8M
Inventory	$242.3M+4.7%	$231.4M+8.6%	$213.1M-22.9%	$276.5M+30.3%	$212.2M+115.8%	$98.3M	N/A
Accounts Receivable	$10.5M+26.7%	$8.3M+23.6%	$6.7M+3.0%	$6.5M-26.5%	$8.9M+2774.7%	$308K	N/A
Goodwill	$483.9M0.0%	$483.9M0.0%	$483.9M-38.9%	$791.5M+3.4%	$765.4M+1039.3%	$67.2M+818.2%	$7.3M
Total Liabilities	$1.6B-4.2%	$1.6B+22.8%	$1.3B-10.3%	$1.5B+16.6%	$1.3B+249.2%	$361.9M	N/A
Current Liabilities	$126.9M-8.3%	$138.5M+20.6%	$114.8M-45.4%	$210.3M+24.5%	$168.9M+121.9%	$76.1M	N/A
Long-Term Debt	$136.7M-62.5%	$364.8M+0.4%	$363.2M-32.9%	$541.7M+17.0%	$462.9M	N/A	N/A
Total Equity	$1.1B-8.5%	$1.2B-11.3%	$1.4B-26.9%	$1.9B-10.2%	$2.1B+379.4%	$447.9M+237.1%	$132.9M
Retained Earnings	-$912.1M-14.6%	-$795.7M-24.2%	-$640.6M-462.7%	-$113.8M-182.7%	$137.7M+15.1%	$119.7M	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$2.8B+3.2%	$2.7B-8.3%	$2.9B+0.7%	$2.9B+1.2%	$2.9B+0.6%	$2.9B-0.1%	$2.9B+0.3%	$2.9B
Current Assets	$653.0M+16.0%	$562.7M-25.6%	$756.4M+6.3%	$711.4M+9.5%	$649.4M+7.4%	$604.6M+0.3%	$603.0M-4.4%	$631.1M
Cash & Equivalents	$352.9M+38.1%	$255.5M-43.1%	$449.2M+14.4%	$392.6M+19.5%	$328.5M+37.5%	$238.8M+0.5%	$237.7M-33.1%	$355.2M
Inventory	$242.3M0.0%	$242.3M-0.4%	$243.3M+0.8%	$241.5M+0.9%	$239.3M+3.4%	$231.4M+4.7%	$220.9M+6.4%	$207.6M
Accounts Receivable	$14.1M+33.8%	$10.5M0.0%	$10.5M-2.5%	$10.8M+4.9%	$10.3M+23.8%	$8.3M-8.2%	$9.0M+19.9%	$7.5M
Goodwill	$483.9M0.0%	$483.9M0.0%	$483.9M0.0%	$483.9M0.0%	$483.9M0.0%	$483.9M0.0%	$483.9M0.0%	$483.9M
Total Liabilities	$1.6B+5.1%	$1.6B-11.5%	$1.8B+2.5%	$1.7B+2.6%	$1.7B+2.9%	$1.6B+3.5%	$1.6B+5.2%	$1.5B
Current Liabilities	$124.2M-2.2%	$126.9M+2.3%	$124.1M+0.2%	$123.8M-9.4%	$136.7M-1.3%	$138.5M+1.3%	$136.7M+10.4%	$123.8M
Long-Term Debt	$195.6M+43.1%	$136.7M-62.7%	$366.1M+0.1%	$365.7M+0.1%	$365.3M+0.1%	$364.8M+0.1%	$364.4M+0.1%	$364.0M
Total Equity	$1.1B+0.6%	$1.1B-3.6%	$1.2B-1.9%	$1.2B-0.8%	$1.2B-2.4%	$1.2B-4.0%	$1.3B-5.1%	$1.4B
Retained Earnings	-$909.7M+0.3%	-$912.1M-4.9%	-$869.2M-3.2%	-$842.4M-1.7%	-$828.6M-4.1%	-$795.7M-8.1%	-$736.0M-8.9%	-$675.7M

TCNNF Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TCNNF quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	$277.4M	$272.8M+0.5%	$271.5M+34.5%	$201.8M+773.9%	$23.1M+79.1%	$12.9M-87.1%	$99.6M+422.4%	$19.1M
Capital Expenditures	$40.8M	$44.2M-64.0%	$122.6M+204.7%	$40.2M-75.6%	$164.7M-40.3%	$275.9M+176.1%	$99.9M+39.1%	$71.8M
Free Cash Flow	$236.6M	$228.6M+53.6%	$148.9M-7.9%	$161.6M+214.1%	-$141.7M+46.1%	-$263.0M-88156.4%	-$298K+99.4%	-$52.8M
Investing Cash Flow	-$42.7M	$13.5M+106.5%	-$206.6M-451.4%	-$37.5M+82.6%	-$215.1M+0.1%	-$215.2M-23.2%	-$174.7M-84.5%	-$94.7M
Financing Cash Flow	-$211.2M	-$270.5M-708.9%	-$33.4M+81.0%	-$175.6M-198.8%	$177.8M-38.5%	$289.2M+122.6%	$129.9M-9.1%	$143.0M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$55.7M-5.9%	$59.2M-22.9%	$76.8M-10.4%	$85.7M+67.6%	$51.1M+66.7%	$30.7M+1.1%	$30.3M-57.5%	$71.3M
Capital Expenditures	$13.5M+295.3%	$3.4M-72.3%	$12.3M+6.6%	$11.6M-31.5%	$16.9M-60.5%	$42.7M+12.0%	$38.1M+45.0%	$26.3M
Free Cash Flow	$42.2M-24.3%	$55.8M-13.4%	$64.4M-13.1%	$74.1M+116.5%	$34.2M+384.8%	-$12.0M-54.6%	-$7.8M-117.3%	$45.0M
Investing Cash Flow	-$13.2M-123.8%	-$5.9M+61.7%	-$15.4M-86.7%	-$8.2M-119.2%	$43.0M+285.6%	-$23.2M+82.4%	-$131.5M-298.7%	-$33.0M
Financing Cash Flow	$54.8M+121.5%	-$255.4M-5251.9%	-$4.8M+18.2%	-$5.8M-29.7%	-$4.5M+29.2%	-$6.4M+61.1%	-$16.4M-78.5%	-$9.2M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

TCNNF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

TCNNF quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	60.2%-0.1pp	60.3%+8.2pp	52.1%-4.4pp	56.6%-4.2pp	60.8%-13.3pp	74.1%-1.8pp	75.9%
Operating Margin	12.2%+3.9pp	8.2%+27.9pp	-19.6%-23.8pp	4.1%-17.8pp	21.9%-20.0pp	41.9%-2.9pp	44.8%
Net Margin	-9.8%+3.2pp	-13.1%+33.6pp	-46.7%-26.5pp	-20.2%-22.1pp	1.9%-10.2pp	12.1%-8.9pp	21.0%
Return on Equity	-10.2%+2.2pp	-12.4%+25.0pp	-37.4%-24.6pp	-12.8%-13.6pp	0.8%-13.2pp	14.1%-25.9pp	40.0%
Return on Assets	-4.3%+1.1pp	-5.4%+13.9pp	-19.3%-12.1pp	-7.2%-7.8pp	0.5%-7.2pp	7.8%	N/A
Current Ratio	4.43+0.1x	4.37+0.2x	4.16+1.3x	2.82-0.3x	3.10-0.3x	3.43	N/A
Debt-to-Equity	0.12-0.2x	0.290.0x	0.260.0x	0.28+0.1x	0.22-0.6x	0.81	N/A
FCF Margin	19.4%+6.8pp	12.6%-1.8pp	14.3%+25.9pp	-11.6%+16.6pp	-28.2%-28.2pp	-0.1%+20.8pp	-20.9%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	59.3%-0.4pp	59.8%+0.8pp	58.9%-1.6pp	60.6%-1.0pp	61.5%-0.6pp	62.1%+1.1pp	61.0%+1.1pp	59.9%
Operating Margin	12.5%+7.2pp	5.2%-9.4pp	14.7%-2.8pp	17.4%+6.2pp	11.2%+10.8pp	0.4%+0.2pp	0.2%-16.2pp	16.4%
Net Margin	0.8%+13.7pp	-12.9%-2.9pp	-10.0%-4.7pp	-5.3%+6.0pp	-11.3%+7.6pp	-18.9%+2.7pp	-21.7%-17.7pp	-4.0%
Return on Equity	0.2%+3.5pp	-3.3%-0.9pp	-2.4%-1.1pp	-1.3%+1.4pp	-2.8%+1.8pp	-4.6%+0.2pp	-4.7%-3.9pp	-0.9%
Return on Assets	0.1%+1.5pp	-1.4%-0.4pp	-1.0%-0.4pp	-0.5%+0.6pp	-1.2%+0.8pp	-2.0%+0.1pp	-2.1%-1.7pp	-0.4%
Current Ratio	5.26+0.8x	4.43-1.7x	6.09+0.3x	5.74+1.0x	4.75+0.4x	4.370.0x	4.41-0.7x	5.10
Debt-to-Equity	0.17+0.1x	0.12-0.2x	0.310.0x	0.300.0x	0.300.0x	0.290.0x	0.280.0x	0.27
FCF Margin	14.7%-4.3pp	19.0%-3.3pp	22.4%-2.2pp	24.5%+13.0pp	11.5%+15.5pp	-4.0%-1.2pp	-2.7%-17.6pp	14.8%

Similar Companies

Green Thum GTBIF

$1.7B

Nika Pharmaceuticals NIKA

$429.9M

Curaleaf Hldgs CURLF

$2.6B

Endo Inc NDOI

$1.8B

Evotec Se EVOTF

$1.3B

Where Trulieve Cannabis Corp Ranks

Frequently Asked Questions

What is Trulieve Cannabis Corp's annual revenue?

Trulieve Cannabis Corp (TCNNF) reported $1.2B in total revenue for fiscal year 2025. This represents a -0.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Trulieve Cannabis Corp's revenue growing?

Trulieve Cannabis Corp (TCNNF) revenue declined by 0.4% year-over-year, from $1.2B to $1.2B in fiscal year 2025.

Is Trulieve Cannabis Corp profitable?

No, Trulieve Cannabis Corp (TCNNF) reported a net income of -$116.4M in fiscal year 2025, with a net profit margin of -9.8%.

What is Trulieve Cannabis Corp's EBITDA?

Trulieve Cannabis Corp (TCNNF) had EBITDA of $261.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Trulieve Cannabis Corp have?

As of fiscal year 2025, Trulieve Cannabis Corp (TCNNF) had $255.5M in cash and equivalents against $136.7M in long-term debt.

What is Trulieve Cannabis Corp's gross margin?

Trulieve Cannabis Corp (TCNNF) had a gross margin of 60.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Trulieve Cannabis Corp's operating margin?

Trulieve Cannabis Corp (TCNNF) had an operating margin of 12.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Trulieve Cannabis Corp's net profit margin?

Trulieve Cannabis Corp (TCNNF) had a net profit margin of -9.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Trulieve Cannabis Corp's return on equity (ROE)?

Trulieve Cannabis Corp (TCNNF) has a return on equity of -10.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Trulieve Cannabis Corp's free cash flow?

Trulieve Cannabis Corp (TCNNF) generated $228.6M in free cash flow during fiscal year 2025. This represents a 53.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Trulieve Cannabis Corp's operating cash flow?

Trulieve Cannabis Corp (TCNNF) generated $272.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Trulieve Cannabis Corp's total assets?

Trulieve Cannabis Corp (TCNNF) had $2.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Trulieve Cannabis Corp's capital expenditures?

Trulieve Cannabis Corp (TCNNF) invested $44.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Trulieve Cannabis Corp have outstanding?

Trulieve Cannabis Corp (TCNNF) had 192M shares outstanding as of fiscal year 2025.

What is Trulieve Cannabis Corp's current ratio?

Trulieve Cannabis Corp (TCNNF) had a current ratio of 4.43 as of fiscal year 2025, which is generally considered healthy.

What is Trulieve Cannabis Corp's debt-to-equity ratio?

Trulieve Cannabis Corp (TCNNF) had a debt-to-equity ratio of 0.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Trulieve Cannabis Corp's return on assets (ROA)?

Trulieve Cannabis Corp (TCNNF) had a return on assets of -4.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Trulieve Cannabis Corp's Altman Z-Score?

Trulieve Cannabis Corp (TCNNF) has an Altman Z-Score of 1.19, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Trulieve Cannabis Corp's Piotroski F-Score?

Trulieve Cannabis Corp (TCNNF) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Trulieve Cannabis Corp's earnings high quality?

Trulieve Cannabis Corp (TCNNF) reported a net loss of $116.4M while generating $272.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Trulieve Cannabis Corp cover its interest payments?

Trulieve Cannabis Corp (TCNNF) has an interest coverage ratio of 2.26x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.